If you saw the headline and wondered whether you can file for a piece of the $440 million, the short answer is no — this is money the government recovers, not a consumer settlement. Here is what the deal actually resolves.
What Is This About?
CVS Health Corporation and its long-term-care pharmacy subsidiary Omnicare, Inc. have agreed to pay $440 million to resolve the federal government's False Claims Act case against them — a case a jury had already decided in the government's favor. The agreement was disclosed in a July 1, 2026 filing in Omnicare's Chapter 11 bankruptcy in the U.S. Bankruptcy Court for the Northern District of Texas, and it compromises a judgment that had grown to roughly $948.8 million. The settlement is expressly not an admission of liability, and it still needs the bankruptcy court's approval; a hearing is set for August 12, 2026.Omnicare is the largest institutional pharmacy in the country, dispensing medications to residents of nursing homes, assisted-living communities, and other long-term-care facilities. CVS bought it in August 2015. After the judgment landed, Omnicare filed for Chapter 11 bankruptcy in September 2025, and the $440 million deal is being worked out inside that bankruptcy so the government's claim — and other creditors' claims — can be resolved.
What the Jury Found
The settlement follows a full trial. On April 29, 2025, after a four-week trial in the U.S. District Court for the Southern District of New York, a Manhattan jury found Omnicare liable under the False Claims Act. According to the U.S. Attorney's Office for the Southern District of New York, the jury found that Omnicare billed Medicare, Medicaid, and TRICARE for more than 3 million false claims, causing $135,592,814 in damages, and that CVS was liable for causing Omnicare to submit more than a million of those claims after the 2015 acquisition.The government's case centered on how Omnicare kept prescriptions flowing at long-term-care and assisted-living facilities. Prosecutors said that rather than obtaining new prescriptions when old ones expired or ran out of refills, Omnicare's pharmacies used a "rollover" process that assigned new prescription numbers and kept dispensing the same drugs to elderly and disabled residents — without the new paperwork and pharmacist review the rules require — then billed the government health programs for those drugs. The jury agreed that conduct produced false claims.
In August 2025, the court entered judgment based on the verdict: treble damages of $406,778,442 plus statutory penalties, bringing the total to roughly $948.8 million, with CVS held jointly liable for part of it. That judgment — not the settlement — is the figure the $440 million compromises.
Free settlement alerts
Get notified when new class actions open to claims
Join thousands of readers who get the latest class action settlements you may qualify for — delivered straight to your inbox.
Why $440 Million Instead of $948 Million?
A False Claims Act judgment that size is an existential problem for a company, and Omnicare responded by filing for Chapter 11 bankruptcy in September 2025. In bankruptcy, a nine-figure judgment becomes a claim to be negotiated alongside everyone else the company owes. The $440 million is the number the parties reached to settle the government's claim within that process. According to the July 1, 2026 filing, resolving the government's claim at $440 million gives the estate "the best chance that all other general unsecured claims will be paid in full."The payment is structured over time: CVS would pay $130 million within 14 days of a final agreement and the remaining $310 million by March 15, 2028. Because it is a compromise reached to avoid further litigation and appeals, the settlement carries no admission of liability — a standard feature of these deals, and one that does not erase the jury's underlying findings.
Is There Any Money for Consumers?
No. This is worth stating plainly because the dollar figure invites the question: there is no consumer claim form, no settlement fund for patients, and nothing for the public to file. A False Claims Act recovery is money the defendant pays back to the government for having billed federal health programs improperly. It flows to the U.S. Treasury and the affected programs, not to individuals.The one private party who does share in the money is the whistleblower. The case began as a qui tam (whistleblower) lawsuit filed in 2015 by Uri Bassan, a former Omnicare pharmacist, and the government intervened in 2019. Under the False Claims Act, a whistleblower is entitled to a share of the recovery — typically between 15% and 25% when the government takes over the case. That is the only slice of the $440 million earmarked for a private person, and it is set by statute, not by any claim you could file. If you are looking for a government-ordered payout you actually receive, that works differently — see, for example, how the Cash App CFPB redress checks reach consumers automatically, or how a government enforcement deal with no consumer money looks in the DOJ egg price-fixing settlement.
What Happens Next
The deal is not final until the bankruptcy court approves it. The court has scheduled an August 12, 2026 hearing on the settlement. If it is approved, the payment schedule above takes effect and the government's claim against Omnicare and CVS is resolved. Separately, the outcome does not by itself create any new right for nursing-home residents or their families to recover money; anyone who believes they were personally harmed by a billing or medication issue would have to pursue that through other channels.Frequently Asked Questions
Is there a claim form or money for consumers in the Omnicare settlement?
No. This is a federal False Claims Act recovery, not a class action. The $440 million goes to the U.S. government (and a whistleblower share), not to individual patients. There is no consumer claim form, no settlement fund for the public, and nothing to file.
How much are CVS and Omnicare paying, and when?
Under the agreement disclosed July 1, 2026, CVS would pay $440 million total: $130 million within 14 days of a final agreement and the remaining $310 million by March 15, 2028. The deal remains subject to bankruptcy-court approval, with a hearing set for August 12, 2026.
What did the jury find Omnicare did?
On April 29, 2025, a Manhattan federal jury found that Omnicare dispensed drugs to nursing-home and assisted-living residents on expired or invalid prescriptions and billed Medicare, Medicaid, and TRICARE, resulting in more than 3 million false claims and $135,592,814 in damages. The jury also found CVS liable for causing claims after it bought Omnicare in 2015.
Why is CVS paying $440 million instead of the $948 million judgment?
After the verdict the court entered a judgment of roughly $948.8 million (treble damages plus statutory penalties). Omnicare filed for Chapter 11 bankruptcy in September 2025, and the $440 million is a negotiated compromise of that judgment reached in the bankruptcy. It is not an admission of liability and still needs court approval.
Who is Omnicare and how is it related to CVS?
Omnicare is the largest long-term-care pharmacy in the U.S., supplying medications to nursing homes and assisted-living facilities. CVS Health acquired it in August 2015. The court found CVS jointly liable as the parent for causing Omnicare to submit false claims after the acquisition.
Sources
- U.S. Attorney's Office, S.D.N.Y. — Statement on the Verdict in U.S. v. Omnicare and CVS Health Corporation
- Bloomberg Law — CVS, Bankrupt Unit Omnicare Reach $440 Million Deal With U.S.
- Law360 — Omnicare, CVS Reach $440M Ch. 11 Settlement With DOJ
- Senior Housing News — Omnicare, CVS Health Agree to $440M Settlement in False Claims Act Case
- Healthcare Dive — CVS, Omnicare Hit With $949M Judgment
